shadow shadow shadow shadow shadow
    Country
    Opportunity Status
    Funding Instrument Type
    Category
    Clear

    Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)

    PAR-24-206

    National Institutes of Health

    Opening date 2 Apr 2024, 12:00AM

    Closing date 13 Aug 2024, 12:00AM

    Funding Opportunity Number: PAR-24-206

    Opportunity Category: Discretionary

    CFDA Number(s): 93.121 -- Oral Diseases and Disorders Research,93.172 -- Human Genome Research,93.173 -- Research Related to Deafness and Communication Disorders,93.233 -- National Center on Sleep Disorders Research,93.350 -- National Center for Advancing Translational Sciences,93.837 -- Cardiovascular Diseases Research,93.838 -- Lung Diseases Research,93.839 -- Blood Diseases and Resources Research,93.840 -- Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders,93.846 -- Arthritis, Musculoskeletal and Skin Diseases Research,93.847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research,93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders,93.855 -- Allergy and Infectious Diseases Research,93.865 -- Child Health and Human Development Extramural Research,93.866 -- Aging Research

    Cost Sharing or Matching Requirement: No

    Posted Date: Apr 02, 2024 12:00:00 AM EDT

    Closing Date: Aug 13, 2024 12:00:00 AM EDT

    Award Ceiling: $1000000

    Award Floor: none

    Eligible Applicants: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education,Public housing authorities/Indian housing authorities,State governments,Native American tribal organizations (other than Federally recognized tribal governments),County governments,Public and State controlled institutions of higher education,City or township governments,For profit organizations other than small businesses,Special district governments,Others (see text field entitled "Additional Information on Eligibility" for clarification),Small businesses,Independent school districts,Native American tribal governments (Federally recognized),Private institutions of higher education,Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education

    Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

    Agency Name: National Institutes of Health

    Description:

    The objective of this Notice of Funding Opportunity (NOFO) is to invite new and renewal applications for the Rare Diseases Clinical Research Consortia (RDCRC) that comprise the Rare Diseases Clinical Research Network (RDCRN). The RDCRCs are intended to advance and improve diagnosis, management, and treatment of numerous, diverse rare diseases through highly collaborative, multi-site, patient-centric, translational and clinical research. Special emphasis will be placed on the early and timely identification of individuals with rare diseases and clinical trial readiness.

    Grantor Contact Information: NIH Grants Information grantsinfo@nih.gov

    We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.

    We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.

    • Required to run the website
    • Monitoring website usage and optimizing the user experience
    • Evaluation of marketing actions
    • Storage of your preferences from previous visits
    • Collecting user feedback to improve our website
    • Recording of your interests in order to provide customised content and offers
    Cookie Settings Accept